Doctor breaks down study showing GLP-1s may lower breast cancer risk
A new study of more than 111,000 women ages 45 to 80 found those on GLP-1 medications had a reduced risk of developing breast cancer by about 30%.
America Forever Bytes
GLP-1 · AFBytes
Technology
GLP-1
Recent coverage
Microbiologist Lists Grocery Items That May Help Boost the Body’s Own GLP-1 Production
Find out how GLP-1 (Glucagon-like peptide-1) natural production influences fullness and sugar metabolism based on gut health.
Alarming rise in weight loss drug overdoses
In an investigative report in partnership with KFF Health News, NBC News’ Anne Thompson reports on the growing cases of overdoses involving GLP-1 weight loss ...
After the Prescription: The Clinical Support Gap in Telehealth-Based GLP-1 Care
GLP-1 medications offer promise for obesity management and are increasingly accessible via digital platforms. In this News and Perspectives article, JMIR Corres...
Everyone’s on GLP-1s. But at What Cost?
As compounded versions proliferate, reports of eating disorders and adolescent use are on the rise.
Scientists Identify Hidden Brain Pathway Behind GLP-1 Weight-Loss Effects
A new study shows oral GLP-1 drugs suppress hedonic eating through a deep-brain reward circuit linked to dopamine release, potentially extending their use beyon...